REGENERON PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
REGENERON PHARMACEUTICALS, INC. (REGN) had Property, Plant and Equipment, Gross of $3.81 billion as of 2019-12-31, per its 10-K filed 2020-02-07.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2020-02-07
- 2019-12-31: Property, Plant and Equipment, Gross $3.81B.
- 2018-12-31: Property, Plant and Equipment, Gross $3.30B.
- 2017-12-31: Property, Plant and Equipment, Gross $2.92B; Property, Plant and Equipment, Gross as first filed $2.92B.
- 2016-12-31: Property, Plant and Equipment, Gross $2.51B.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2019-12-31 | $3.81B 10-K · filed 2020-02-07 | |
| 2018-12-31 | $3.30B 10-K · filed 2020-02-07 | |
| 2017-12-31 | $2.92B 10-K · filed 2019-02-07 | $2.92B 10-K · filed 2018-02-08 |
| 2016-12-31 | $2.51B 10-K · filed 2018-02-08 | |
| 2015-12-31 | $1.93B 10-K · filed 2017-02-09 | |
| 2014-12-31 | $1.23B 10-K · filed 2016-02-11 | |
| 2013-12-31 | $748.60M 10-K · filed 2015-02-12 | |
| 2012-12-31 | $560.45M 10-K · filed 2014-02-13 | |
| 2011-12-31 | $526.09M 10-K · filed 2013-02-15 | |
| 2010-12-31 | $478.76M 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |